(1R,1'S,3'R/1R,1'R,3'S)-L-054,264

Modify Date: 2024-09-14 18:00:23

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 Structure
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 structure
Common Name (1R,1'S,3'R/1R,1'R,3'S)-L-054,264
CAS Number 208706-12-1 Molecular Weight 539.71
Density N/A Boiling Point N/A
Molecular Formula C33H41N5O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (1R,1'S,3'R/1R,1'R,3'S)-L-054,264


(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 is a selective non-peptide human somatostatin receptor subtype 2 (sst2) agonist. (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 can be used in the study of retinal neuromodulation[1][2].

 Names

Name N-[1-(cyclohexylmethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl]spiro[indene-1,4'-piperidine]-1'-carboxamide

 (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 Biological Activity

Description (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 is a selective non-peptide human somatostatin receptor subtype 2 (sst2) agonist. (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 can be used in the study of retinal neuromodulation[1][2].
Related Catalog
References

[1]. Yang L, et al. Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists. J Med Chem. 1998 Jun 18;41(13):2175-9.  

[2]. Weir K, et al. A potential role for somatostatin signaling in regulating retinal neurogenesis. Sci Rep. 2021 May 26;11(1):10962. doi: 10.1038/s41598-021-90554-3. Erratum in: Sci Rep. 2021 Aug 16;11(1):16948.  

 Chemical & Physical Properties

Molecular Formula C33H41N5O2
Molecular Weight 539.71
Exact Mass 539.32600
PSA 103.25000
LogP 6.15050
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 suppliers

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 price

Related Compounds: More...
(1R,1'S)-Octahydro-1-(2'-iodo-1'-Methylethyl)-7a-Methyl-inden-4-one
145372-32-3
(1R,1'R,3S,3'S)-3,3'-(phenylphosphoryl)bis(1,7,7-trimethylbicyclo[2.2.1]heptan-2-one)
672939-06-9
(1r,1's,4R,4'S)-1,1',4,4'-tetramethyl-1,1'-bi(cyclohexane)
117503-07-8
(1r,1's,4r,4'S)-4-(4-Isothiocyanatophenyl)-4'-propyl-1,1'-bi(cyclohexyl)
100822-04-6
((1R,1'S)-2,2,2',2'-tetramethyl-[1,1'-bi(cyclopropane)]-1,1'-diyl)dibenzene
84731-18-0
(1R,1'S,2S,2'R,3R)-2'-((tert-butyldiphenylsilyl)oxy)-3-(prop-1-en-2-yl)-[1,1'-bi(cyclopentan)]-2-ol
1228189-56-7
1R,1'S(+)-tiliacorine
27073-72-9
(1r,1's,4r,4'S)-4-Bromo-4'-pentyl-1,1'-bi(cyclohexyl)
149715-70-8
[4(S)-[trans(trans)]]-1,3-Difluoro-2-[(1-methylheptyl)oxy]-5-(4'-propyl[1,1'-bicyclohexyl]-4-yl)benzene
185207-90-3
N-[5-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-phenyl-acetamide
868974-77-0
N-[5-[2-oxo-2-[3-(trifluoromethyl)anilino]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-phenyl-acetamide
896027-54-6
N-[5-[2-(3-acetamidoanilino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-phenyl-acetamide
868974-78-1
N-[5-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-phenyl-acetamide
868974-83-8
N-[5-[2-(5-chloro-2-methoxy-anilino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-phenyl-acetamide
868974-87-2
N-[5-[2-oxo-2-[3-(trifluoromethyl)anilino]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-(1-piperidylsulfonyl)benzamide
896027-92-2
N-[5-[2-[(4-fluorophenyl)methylamino]-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-(1-piperidylsulfonyl)benzamide
896027-99-9
N-[5-[2-(1,3-benzodioxol-5-ylamino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-pyrrolidin-1-ylsulfonyl-benzamide
896028-06-1
N-[5-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-pyrrolidin-1-ylsulfonyl-benzamide
896028-13-0
N-[5-[2-[(4-fluorophenyl)methylamino]-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-pyrrolidin-1-ylsulfonyl-benzamide
896028-20-9